Time-to-event modeling for achieving a stable warfarin dose using genetic and non-genetic covariates
Advances in Clinical and Experimental Medicine · 2023
DOI: 10.17219/acem/161155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Kannan Sridharan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain. Hauptthemen laut MEDLINE: Warfarin, Aryl Hydrocarbon Hydroxylases. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain.
- Department of Cardiology, Salmaniya Medical Complex, Manama, Bahrain.
Zitieren
APA
Sridharan, K., Banna, R. A. A., & Husain, A. (2023). Time-to-event modeling for achieving a stable warfarin dose using genetic and non-genetic covariates. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/161155
Vancouver
Sridharan K, Banna RAA, Husain A. Time-to-event modeling for achieving a stable warfarin dose using genetic and non-genetic covariates. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/161155
BibTeX
@article{Sridharan2023,
author = {Sridharan, Kannan and Banna, Rashed Abdulla Al and Husain, Aisha},
title = {Time-to-event modeling for achieving a stable warfarin dose using genetic and non-genetic covariates},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
doi = {10.17219/acem/161155}
}
EUVIMED